Работы, цитирующие эту работу

Работ: 2

Работа: Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

1. Exploring cellular immunotherapy platforms in multiple myeloma

   Manh-Cuong Vo, Sunghoon Jung, Van‐Tan Nguyen +11

   СтатьяCAR-T cell therapy researchHeliyon2024Цитирований: 1

   ABIABI:AkademIndex/openalex/2026.other.102962

2. The role and prognostic value of the interleukin 2 gene at multiple myeloma

   G. Z. Makhamadaliyeva, A. A. Kayumov, Nilufar Akhrarova +1

   СтатьяMultiple Myeloma Research and TreatmentsMedicine and ecology2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.article.008843